CLOSE X

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5021.3029 (+0.58 %)
PREV CLOSE ( ) 4992.30
OPEN PRICE ( ) 5000.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1473
TODAY'S LOW / HIGH ( )5000.00 5080.00
52 WK LOW / HIGH ( )4699.7 6700
NSE5022.9025.2 (+0.5 %)
PREV CLOSE( ) 4997.70
OPEN PRICE ( ) 5009.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5022.90 (461)
VOLUME 16941
TODAY'S LOW / HIGH( ) 4990.00 5079.90
52 WK LOW / HIGH ( )4707 6739
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1967
Management Info
S Madhavan - Chairman Milind Thatte - Managing Director
Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
26Aug Procter & Gamble Health re-submits an
With reference to its earlier communication dated August 6, 2025, Procte..
06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Annual Rep..
06Aug Procter & Gamble Health informs about
Procter & Gamble Health has informed that it enclosed the Business R..
17Jun Procter & Gamble Health informs about
With reference to the virtual connect with analysts/ institutional inves..
11Jun Procter & Gamble Health informs about
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
Financials
in Millions
QTR Dec 25 ANNUAL 24
Net Profit775.92009.8
Gross Profit 1088.2 2733.2
Operating Profit 1148.23216.3
Net Sales 3738.611512.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  15301.65 (2.11%)
M.Cap ( in Cr)19631.85
RPG Life Sciences (BSE)
up  2025.85 (6.63%)
M.Cap ( in Cr)3350.56
Pfizer (BSE)
up  4954.05 (1.74%)
M.Cap ( in Cr)22663.66
Kwality Pharma (BSE)
up  1747.00 (4.01%)
M.Cap ( in Cr)1812.72
Gland Pharma (BSE)
up  1795.80 (3.44%)
M.Cap ( in Cr)29586.96
Shareholding Pattern
PROMOTERS 51.82%
NON-INSTITUTION 27.37%
MUTUAL FUNDS/UTI 10.48%
FI/BANKS/INSURANCE 3.15%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
UTI MNC Fund-Reg(IDCW)4.94
UTI Healthcare Fund-Reg(IDCW)4.30
Sundaram LT Tax Adv Fund-Sr IV-Reg(G)3.15
DSP Healthcare Fund-Reg(G)3.06
Sundaram LT Tax Adv Fund-Sr III-Reg(G)2.94
Sundaram LT Micro Cap Tax Adv Fund-Sr V-Reg(G)2.91
Sundaram LT Micro Cap Tax Adv Fund-Sr VI-Reg(G)2.82
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors